Advertisement
Advertisement

VTYX

VTYX logo

Ventyx Biosciences Inc

2.34
USD
-0.035
-1.48%
Dec 18, 15:04 UTC -5
Open

Ventyx Biosciences Inc Profile

About

Ventyx Biosciences Inc. is a clinical-stage biopharmaceutical company. It focused on advancing new therapies for patients living with inflammatory diseases and autoimmune disorders. The company's clinical stage pipeline includes VTX958, VTX002 and VTX2735. Ventyx Biosciences Inc. is headquartered in Encinitas, California.

Info & Links

CEO

Raju Mohan

Headquarters

12790 EL CAMINO REAL, SUITE 200
SAN DIEGO, CA 92130, UNITED STATES

Auditor

Ernst & Young LLP

Share holders

19

Employees

80

Ventyx Biosciences Inc Statistics

Valuation Measures

Market Capitalization2

165.11M

Enterprise Value

103.34M

Enterprise Value/EBITDA(ttm)

-0.63

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

0.58

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-54.94%

Return on Invested Capital(ttm)

-55.75%

Return on Assets(ttm)

-50.01%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-164.94M

Net Income Available to Common(ttm)

-152.52M

Diluted EPS(ttm)

-2.36

Share Statistics

Beta (5Y Monthly)

0.48

52-Week Change

6.62%

S&P 500 52-Week Change

26.31%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

70.71M

Dividend Yield

0.00%

Float4

57.86M

% Held by Insiders

18.18%

% Held by Institutions

97.88%

Balance Sheet

Total Cash(mrq)

274.82M

Total Cash Per Share(mrq)

3.89

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

23.52%

Quick Ratio(mrq)

23.52%

Book Value Per Share(mrq)

3.94

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.52

Free Cash Flow(ytd)

-107.86M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement